Elizabeth Whittington

Harmony Hill cancer retreats modeled after well-known predecessor.

Ovarian Cancer Alliance launches social networking site.

Gary Zollinger's legacy lives on through early detection research.

Blood counts predict leukemia survival and relapse.

Senate passes the Conquer Childhood Cancer Act for research funding.

Are breast cancer rates dropping because of the HRT decline, or are other factors at work?

Breast cancer survivors look for alternatives to HRT to quell their hot flashes, including antidepressants, antiseizure medications, and integrative therapies.

Five years after the results of the Women’s Health Initiative were announced linking combined hormone replacement therapy to an increased risk of breast cancer, research continues on its benefits and risks.

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.

Texas may become the next state to self-fund cancer research.

Lance Armstrong, Robin Roberts, and Beverly Sills.

The Colon Cancer Alliance hosts the 7th Annual Colorectal Cancer Conference October 12-14, 2008.

Delayed diagnosis too common.

Tom Butler-Bowdon recounts 50 Spiritual Classics.

Cancer survivor parks provide inspirational playground.

American Cancer Society launches ambitious prevention study.

Avatars walk for cancer in Second Life’s virtual relay.

Brian Durie, MD, and Susan Novis, president of the International Myeloma Foundation, answer questions about the progress in multiple myeloma.

Companies and public banks collect and store blood from the umbilical cord and placenta for stem cell transplants to treat blood disorders such as leukemia or lymphoma.

Surgeons learn new minimally invasive and robotic surgery techniques to remove and find early-stage tumors.

Terminal cancer patients whose tumors don’t respond to standard treatment have limited options, especially those with aggressive cancers that have become resistant to various treatment regimens.

Therapies that preferentially target lung cancers harboring certain EGFR mutations can be effective in some lung cancers in never-smokers.

Although non-small cell lung cancer is the most common type of lung cancer, a handful of other primary cancers affect the delicate organ.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Genetic nondiscrimination bill on its way to becoming law.

The Anderson Network's Living Fully with and Beyond Cancer conference in Houston.

Elizabeth Edwards and Tony Snow.

A second HPV vaccine proves effective in preventing cervical cancer.

Gamers take virtual shot at cancer.

14-year-old brain tumor survivor Jimmy Fowkes turns shaved heads and a bike into cash for cancer.